Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

Pancreatic Cancer

2000 • 7,332 citations

Hospital Volume and Surgical Mortality in the United States

2002 • 4,818 citations

Cancer Statistics, 2003

2003 • 3,302 citations

Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis

1993 • 1,739 citations

Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators

2000 • 1,478 citations

Pancreatic Cancer

1985 • 1,410 citations

TEEATMENT OF CARCINOMA OF THE AMPULLA OF VATER

1935 • 1,329 citations

Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary Region

1999 • 1,249 citations

Cholangiocarcinoma

1996 • 1,150 citations

Survival After Pancreatoduodenectomy

1990 • 1,105 citations

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

2001 • 1,078 citations

Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients

1995 • 950 citations

Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2

2002 • 810 citations

One Hundred and Forty-Five Consecutive Pancreaticoduodenectomies Without Mortality

1993 • 795 citations

Prognostic indicators for survival after resection of pancreatic adenocarcinoma

1993 • 763 citations

Ten-Year Experience With 733 Pancreatic Resections

2001 • 762 citations

Long-Term Survival After Curative Resection for Pancreatic Ductal Adenocarcinoma

1996 • 699 citations

Improved Hospital Morbidity, Mortality, and Survival after the Whipple Procedure

1987 • 695 citations

Standard Versus Extended Lymphadenectomy Associated With Pancreatoduodenectomy in the Surgical Treatment of Adenocarcinoma of the Head of the Pancreas

1998 • 690 citations

Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves Survival

1997 • 600 citations

Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer

1991 • 538 citations

Patterns of failure after curative resection of pancreatic carcinoma

1990 • 442 citations

Recurrence after resection for ductal adenocarcinoma of the pancreas

1997 • 414 citations

Pylorus Preserving Pancreaticoduodenectomy Versus Standard Whipple Procedure

2004 • 407 citations

Long‐term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25‐Year Experience

2003 • 406 citations

Periampullary Adenocarcinoma

1998 • 391 citations

Relationship between hospital volume and late survival after pancreaticoduodenectomy

1999 • 379 citations

Practical Usefulness of Lymphatic and Connective Tissue Clearance for the Carcinoma of the Pancreas Head

1988 • 369 citations

Pancreaticoduodenectomy With or Without Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma

1999 • 365 citations

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre study

1993 • 341 citations

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

2001 • 314 citations

Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.

2000 • 305 citations

Current Developments in Cancer Vaccines and Cellular Immunotherapy

2003 • 300 citations

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

2001 • 298 citations

Quality of Life and Outcomes After Pancreaticoduodenectomy

2000 • 294 citations

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

2000 • 290 citations

Adenocarcinoma of the Ampulla of Vater

1997 • 283 citations

An investigational new drug treatment program for patients with gemcitabine

1999 • 265 citations

Lymph node involvement in carcinoma of the head of the pancreas area

1978 • 263 citations

An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging

1993 • 249 citations

Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs

2003 • 234 citations

Das Carcinom der Papilla duodeni und seine radikale Entfernung

2015 • 232 citations

Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy

1999 • 215 citations

Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study

2003 • 213 citations

An Analysis of the Reduced Morbidity and Mortality Rates After Pancreaticoduodenectomy

1989 • 205 citations

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma

2000 • 203 citations

Prognostic Factors Associated with Resectable Adenocarcinoma of the Head of the Pancreas

1999 • 196 citations

The Advantages of Pylorus-preserving Pancreatoduodenectomy in Malignant Disease of the Pancreas and Periampullary Region

1992 • 182 citations

Occlusion of the Pancreatic Duct Versus Pancreaticojejunostomy

2002 • 167 citations

Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas

2001 • 165 citations

The genetics of pancreatic cancer

2003 • 159 citations

Quality of life, nutritional status, and gastrointestinal hormone profile following the whipple procedure

1995 • 157 citations

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients

2002 • 157 citations

National Patterns of Care for Pancreatic Cancer

1996 • 155 citations

Molecular Prognostic Markers in Pancreatic Cancer

2000 • 154 citations

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16INK4A, p21WAF-1, cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

2000 • 147 citations

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

2002 • 129 citations

Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas.

1992 • 123 citations

Long-term survival after curative resection for pancreatic ductal adenocarcinoma

2004 • 123 citations

Genetic alterations in pancreatic carcinoma.

2003 • 121 citations

Pylorus-Preserving Whipple Resection for Pancreatic Cancer

1995 • 121 citations

The time of occurrence of liver metastasis in carcinoma of the pancreas

1995 • 100 citations

In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of Cyclooxygenase-2 enzyme: mechanistic considerations

2002 • 94 citations

Quality of life and long-term survival after surgery for chronic pancreatitis

2000 • 93 citations

Intraarterial Adjuvant Chemotherapy after Pancreaticoduodenectomy for Pancreatic Cancer: Significant Reduction in Occurrence of Liver Metastasis

1999 • 93 citations

Aggressive surgery for pancreatic duct cell cancer: Feasibility, validity, limitations

1995 • 84 citations

Results of 1001 Pancreatic Resections for Invasive Ductal Adenocarcinoma of the Pancreas

1997 • 84 citations

Surgical Resection After Preoperative Chemoradiotherapy Benefits Selected Patients With Unresectable Pancreatic Cancer

2003 • 75 citations

Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer

1991 • 73 citations

Gastric Emptying and Small Bowel Transit of Solid Food After Pylorus-Preserving Pancreaticoduodenectomy

1987 • 70 citations

Long‐term evaluation of pylorus preservation during pancreaticoduodenectomy

1988 • 65 citations

Targeted therapies for the treatment of cancer

2003 • 63 citations

Survival Statistics Gone Awry

2002 • 52 citations

Phase II Study of Gemcitabine, Cisplatin, and Infusional Fluorouracil in Advanced Pancreatic Cancer

2003 • 51 citations

Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study

2003 • 49 citations

Hereditary Pancreatic Cancer

2001 • 49 citations

Effects of STI571 (gleevec) on pancreatic cancer cell growth.

2003 • 48 citations

Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas

2000 • 46 citations

Regional Targeting Chemoimmunotherapy in Patients Undergoing Pancreatic Resection in an Advanced Stage of Their Disease

2002 • 40 citations

Treatment perspectives in locally advanced unresectable pancreatic cancer

1991 • 40 citations

Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors: Fifty patients

1997 • 33 citations

Chemotherapy in the treatment of cancer of the pancreas

1998 • 31 citations

Pylorus-Preserving or Classical Whipple

2000 • 29 citations

Small carcinoma of the pancreas. Factors of prognostic relevance

1998 • 27 citations

Celecoxib with chemotherapy in colorectal cancer.

2002 • 24 citations

Quality of life measurements do not support palliative pancreatic cancer treatments.

1998 • 20 citations

Gemcitabine and platinum combinations in pancreatic cancer

2002 • 20 citations

Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy

1998 • 19 citations

Celiac artery adjuvant chemotherapy

1997 • 19 citations

Arguments against radical (extended) resection for adenocarcinoma of the pancreas.

1994 • 14 citations

Staging systems for pancreatic cancer: Differences between the Japanese and UICC systems

1998 • 12 citations